Could a daily aspirin protect diabetic Moms-to-Be?
NCT ID NCT03574909
First seen Mar 29, 2026 · Last updated Jun 22, 2026 · Updated 12 times
Summary
This study tested whether taking low-dose aspirin (150 mg) daily, starting in the first trimester, could reduce pregnancy complications in women with type 1 or type 2 diabetes. The trial included 137 women and looked at outcomes like preeclampsia, early preterm birth, low birth weight, and infant death. The goal was to see if this simple, cheap medicine could improve safety for both mother and baby.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-GESTATIONAL DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Rotunda Hospital
Dublin, Ireland
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
low-dose aspirin (150 mg prolonged-release capsule)
What this could lead to
If it works, this could point toward a simple, low-cost way to lower the risk of serious pregnancy complications like preeclampsia and preterm birth in women with diabetes.
What could go wrong
This trial is relatively small (137 participants) and completed, but results may not apply to all women with diabetes. Aspirin also carries a small risk of bleeding or allergic reactions.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.